1[1]International Multicentre Pooled Analysis of Colon Cancer Trials (IMPACT) investigators.Efficacy of adjuvant fluorouracil and folinic acid in colon cancer.Lancet,1995,345:939
2[2]Moertel CG,Fleming TR,Macdonald JS,et al.Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage Ⅲ colon carcinoma:A final report.Ann Intern Med,1995,122:321
3[3]Haller DG,Lefkopoulou M,Macdonald JS,et al.Somg considerations concerning the dose and schedule 5-FU and leucovorin:Toxicities of two dose schedules from the intergroup colon adjuvant trial (INT-0089) Adv Exp Med Biol,1993,339:51
4[4]Haller DG,Catalano PJ,Macdonald JS,et al.Fluorouracil (FU),leucovorin (LV) and levamisole (LEV) adjuvant therapy for colon cancer:Five-year final report of INT -0089.Proc Am Soc Clin Oncol,1998,17:982
5[5]Gill S,Loprinzi CL,Sargent DJ,et al.Pooled analysis of fluorouracil-based adjuvant therapy for stage Ⅱ and Ⅲ colon cancer:Who benefits and by how much? J Clin Oncol,2004,22:1797
6[6]Andre T,Colin P,Louvet C,et al.Semimonthly verses monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage Ⅱ and Ⅲ colon cancer:Results of a randomized trial.J Clin Oncol,2003,21:2896
7[7]Andre T,Quinaux E,Louvet C,et al.Updated results at 6year for the GERCORC96.1 phase Ⅲ study comparing LV5FU2 to monthly 5-FU-leucovorin (mFufol) as adjuvant treatment for Dukes B2 and C colon cancer patients.J Clin Oncol,2005,23:251S
8[8]Carrato A,K(o)hne C,Bedenne L,et al.Folinic acid modulated 5-FU or infusionai 5-FU for adjuvant treatment of patients of UICC stage Ⅲ colon cancer:Preliminary analysis of the PETACC-2-study.J Clin Oncol,2006,24 (Suppl):3563
9[9]Twelves C,Wong A,Nowacki M,et al.Capecitabine as adjuvant treatment for stage Ⅲ colon cancer.N Engl J Med,2005,352:2696
10[10]Wolmark N,Wieand S,Lembersky B,et al.A phase Ⅲcomparing oral UFT to FULV in stage Ⅱ and Ⅲ carcinoma of the colon:Results of NSABP Protocol C-06.Proc Am Soc Clin Oncol,2004,22:247S
